guanfacine hydrochloride
SpainDrugs containing this active substance
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control the symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 1,14 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other medications are not suitable or do not adequately control the symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 2,28 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 3,42 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control the symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 4,56 mg Manufacturer: Takeda Pharmaceuticals International Ag Ireland Branch
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control symptoms. It can help improve attention and concentration, and reduce impulsivity and hyperactivity.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 1,148 mg Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other medications are not suitable or do not adequately control the symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 2,296 mg Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other medications are not suitable or do not adequately control the symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 3,444 mg Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control the symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 4,592 mg Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 5,740 mg Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control the symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 6,88 mg Manufacturer: Neuraxpharm Pharmaceuticals S.L.
-
It is used to treat attention deficit hyperactivity disorder (ADHD) in children and adolescents aged 6 to 17 years when other stimulant medications are not suitable or do not adequately control symptoms.
Form: tablets, prolonged-release
Active substance Dosage guanfacine hydrochloride 8,036 mg Manufacturer: Neuraxpharm Pharmaceuticals S.L.